Logo image of CPAY

CORPAY INC (CPAY) Stock Fundamental Analysis

USA - NYSE:CPAY - US2199481068 - Common Stock

301.93 USD
-3.34 (-1.09%)
Last: 9/19/2025, 8:04:00 PM
301.93 USD
0 (0%)
After Hours: 9/19/2025, 8:04:00 PM
Fundamental Rating

6

CPAY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 101 industry peers in the Financial Services industry. CPAY has an excellent profitability rating, but there are some minor concerns on its financial health. CPAY is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make CPAY suitable for growth investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CPAY had positive earnings in the past year.
CPAY had a positive operating cash flow in the past year.
Each year in the past 5 years CPAY has been profitable.
In the past 5 years CPAY always reported a positive cash flow from operatings.
CPAY Yearly Net Income VS EBIT VS OCF VS FCFCPAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

CPAY's Return On Assets of 5.14% is fine compared to the rest of the industry. CPAY outperforms 76.24% of its industry peers.
CPAY has a Return On Equity of 26.72%. This is amongst the best in the industry. CPAY outperforms 90.10% of its industry peers.
Looking at the Return On Invested Capital, with a value of 10.80%, CPAY belongs to the top of the industry, outperforming 87.13% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CPAY is above the industry average of 7.65%.
Industry RankSector Rank
ROA 5.14%
ROE 26.72%
ROIC 10.8%
ROA(3y)6.24%
ROA(5y)6.25%
ROE(3y)33.21%
ROE(5y)29.98%
ROIC(3y)12.51%
ROIC(5y)11.72%
CPAY Yearly ROA, ROE, ROICCPAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

CPAY has a Profit Margin of 25.17%. This is in the better half of the industry: CPAY outperforms 79.21% of its industry peers.
In the last couple of years the Profit Margin of CPAY has declined.
CPAY's Operating Margin of 43.91% is amongst the best of the industry. CPAY outperforms 84.16% of its industry peers.
In the last couple of years the Operating Margin of CPAY has remained more or less at the same level.
The Gross Margin of CPAY (78.12%) is better than 84.16% of its industry peers.
CPAY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 43.91%
PM (TTM) 25.17%
GM 78.12%
OM growth 3Y0.25%
OM growth 5Y-1.02%
PM growth 3Y-5.18%
PM growth 5Y-5.66%
GM growth 3YN/A
GM growth 5Y-4.82%
CPAY Yearly Profit, Operating, Gross MarginsCPAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

CPAY has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CPAY has been reduced compared to 1 year ago.
The number of shares outstanding for CPAY has been reduced compared to 5 years ago.
The debt/assets ratio for CPAY is higher compared to a year ago.
CPAY Yearly Shares OutstandingCPAY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CPAY Yearly Total Debt VS Total AssetsCPAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

CPAY has an Altman-Z score of 2.02. This is not the best score and indicates that CPAY is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.02, CPAY is doing good in the industry, outperforming 76.24% of the companies in the same industry.
CPAY has a debt to FCF ratio of 4.21. This is a neutral value as CPAY would need 4.21 years to pay back of all of its debts.
CPAY has a Debt to FCF ratio of 4.21. This is in the better half of the industry: CPAY outperforms 72.28% of its industry peers.
A Debt/Equity ratio of 1.91 is on the high side and indicates that CPAY has dependencies on debt financing.
CPAY has a worse Debt to Equity ratio (1.91) than 66.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF 4.21
Altman-Z 2.02
ROIC/WACC1.35
WACC8.01%
CPAY Yearly LT Debt VS Equity VS FCFCPAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

CPAY has a Current Ratio of 1.12. This is a normal value and indicates that CPAY is financially healthy and should not expect problems in meeting its short term obligations.
CPAY's Current ratio of 1.12 is in line compared to the rest of the industry. CPAY outperforms 56.44% of its industry peers.
A Quick Ratio of 1.12 indicates that CPAY should not have too much problems paying its short term obligations.
CPAY has a Quick ratio (1.12) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.12
CPAY Yearly Current Assets VS Current LiabilitesCPAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

7

3. Growth

3.1 Past

CPAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.77%, which is quite good.
CPAY shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.03% yearly.
The Revenue has grown by 9.22% in the past year. This is quite good.
CPAY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.45% yearly.
EPS 1Y (TTM)13.77%
EPS 3Y12.9%
EPS 5Y10.03%
EPS Q2Q%12.75%
Revenue 1Y (TTM)9.22%
Revenue growth 3Y11.94%
Revenue growth 5Y8.45%
Sales Q2Q%12.95%

3.2 Future

The Earnings Per Share is expected to grow by 15.01% on average over the next years. This is quite good.
The Revenue is expected to grow by 10.09% on average over the next years. This is quite good.
EPS Next Y12.93%
EPS Next 2Y14.31%
EPS Next 3Y14.33%
EPS Next 5Y15.01%
Revenue Next Year11.3%
Revenue Next 2Y10.9%
Revenue Next 3Y10.62%
Revenue Next 5Y10.09%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CPAY Yearly Revenue VS EstimatesCPAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
CPAY Yearly EPS VS EstimatesCPAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10 20 30

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.10, which indicates a correct valuation of CPAY.
CPAY's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of CPAY to the average of the S&P500 Index (27.38), we can say CPAY is valued slightly cheaper.
A Price/Forward Earnings ratio of 12.16 indicates a correct valuation of CPAY.
The rest of the industry has a similar Price/Forward Earnings ratio as CPAY.
CPAY is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.1
Fwd PE 12.16
CPAY Price Earnings VS Forward Price EarningsCPAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CPAY indicates a somewhat cheap valuation: CPAY is cheaper than 66.34% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CPAY is valued a bit cheaper than 72.28% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.06
EV/EBITDA 11.76
CPAY Per share dataCPAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 -60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CPAY has a very decent profitability rating, which may justify a higher PE ratio.
CPAY's earnings are expected to grow with 14.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.17
PEG (5Y)1.51
EPS Next 2Y14.31%
EPS Next 3Y14.33%

0

5. Dividend

5.1 Amount

No dividends for CPAY!.
Industry RankSector Rank
Dividend Yield N/A

CORPAY INC

NYSE:CPAY (9/19/2025, 8:04:00 PM)

After market: 301.93 0 (0%)

301.93

-3.34 (-1.09%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners97.31%
Inst Owner Change-9.82%
Ins Owners3.52%
Ins Owner Change1.69%
Market Cap21.32B
Analysts81.9
Price Target393.28 (30.26%)
Short Float %2.32%
Short Ratio3.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.91%
Min EPS beat(2)-2.03%
Max EPS beat(2)-1.79%
EPS beat(4)0
Avg EPS beat(4)-1.76%
Min EPS beat(4)-2.03%
Max EPS beat(4)-1.45%
EPS beat(8)0
Avg EPS beat(8)-1.85%
EPS beat(12)2
Avg EPS beat(12)-1.27%
EPS beat(16)5
Avg EPS beat(16)-0.4%
Revenue beat(2)0
Avg Revenue beat(2)-2.27%
Min Revenue beat(2)-2.93%
Max Revenue beat(2)-1.6%
Revenue beat(4)0
Avg Revenue beat(4)-2.43%
Min Revenue beat(4)-3.5%
Max Revenue beat(4)-1.6%
Revenue beat(8)0
Avg Revenue beat(8)-2.73%
Revenue beat(12)1
Avg Revenue beat(12)-2.06%
Revenue beat(16)5
Avg Revenue beat(16)-1.05%
PT rev (1m)-1.54%
PT rev (3m)-1.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.13%
EPS NY rev (1m)0.29%
EPS NY rev (3m)0.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.63%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)0.55%
Valuation
Industry RankSector Rank
PE 15.1
Fwd PE 12.16
P/S 5.11
P/FCF 11.06
P/OCF 10.08
P/B 5.43
P/tB N/A
EV/EBITDA 11.76
EPS(TTM)20
EY6.62%
EPS(NY)24.84
Fwd EY8.23%
FCF(TTM)27.31
FCFY9.04%
OCF(TTM)29.96
OCFY9.92%
SpS59.08
BVpS55.64
TBVpS-67.66
PEG (NY)1.17
PEG (5Y)1.51
Profitability
Industry RankSector Rank
ROA 5.14%
ROE 26.72%
ROCE 16.97%
ROIC 10.8%
ROICexc 13.11%
ROICexgc 87.43%
OM 43.91%
PM (TTM) 25.17%
GM 78.12%
FCFM 46.23%
ROA(3y)6.24%
ROA(5y)6.25%
ROE(3y)33.21%
ROE(5y)29.98%
ROIC(3y)12.51%
ROIC(5y)11.72%
ROICexc(3y)14.83%
ROICexc(5y)13.92%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.71%
ROCE(5y)16.98%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y1.1%
ROICexc growth 5Y0.59%
OM growth 3Y0.25%
OM growth 5Y-1.02%
PM growth 3Y-5.18%
PM growth 5Y-5.66%
GM growth 3YN/A
GM growth 5Y-4.82%
F-Score7
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF 4.21
Debt/EBITDA 3.42
Cap/Depr 51.24%
Cap/Sales 4.49%
Interest Coverage 3.69
Cash Conversion 96.28%
Profit Quality 183.69%
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z 2.02
F-Score7
WACC8.01%
ROIC/WACC1.35
Cap/Depr(3y)47.52%
Cap/Depr(5y)42.51%
Cap/Sales(3y)4.31%
Cap/Sales(5y)4.03%
Profit Quality(3y)145.81%
Profit Quality(5y)152.95%
High Growth Momentum
Growth
EPS 1Y (TTM)13.77%
EPS 3Y12.9%
EPS 5Y10.03%
EPS Q2Q%12.75%
EPS Next Y12.93%
EPS Next 2Y14.31%
EPS Next 3Y14.33%
EPS Next 5Y15.01%
Revenue 1Y (TTM)9.22%
Revenue growth 3Y11.94%
Revenue growth 5Y8.45%
Sales Q2Q%12.95%
Revenue Next Year11.3%
Revenue Next 2Y10.9%
Revenue Next 3Y10.62%
Revenue Next 5Y10.09%
EBIT growth 1Y7.76%
EBIT growth 3Y12.22%
EBIT growth 5Y7.35%
EBIT Next Year33.23%
EBIT Next 3Y17.77%
EBIT Next 5Y15.62%
FCF growth 1Y40.15%
FCF growth 3Y17.6%
FCF growth 5Y10.19%
OCF growth 1Y37.41%
OCF growth 3Y17.47%
OCF growth 5Y10.8%